Neurotrophic Keratopathy Recruiting Phase 3 Trials for Thymosin beta-4 (DB12003)
Also known as: Neurotrophic Keratitis / Neurotrophic keratitis (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0077055 (Neurotrophic Keratopathy) | Recruiting | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05555589 | Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 | Treatment |